Tums

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of heartburn, acid indigestion, and sour stomach. It is also effective in alleviating upset stomach associated with these symptoms.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are instructed to chew 2 to 4 tablets as symptoms occur, or as directed by a healthcare professional. It is essential that the tablets are chewed or crushed completely before swallowing to ensure proper absorption.

Patients should not use this medication for symptoms that persist for more than 2 weeks without consulting a healthcare provider.

Contraindications

Use of this product is contraindicated in the following situations:

Exceeding a dosage of 6 tablets within a 24-hour period is contraindicated due to the potential for adverse effects. This restriction applies equally to pregnant individuals, who should not exceed this dosage to mitigate risks to both maternal and fetal health.

Additionally, the maximum dosage should not be utilized for more than 2 weeks unless under the guidance and supervision of a healthcare professional, as prolonged use may lead to complications or diminished efficacy.

Warnings and Precautions

Healthcare professionals should be aware of the following warnings and precautions associated with the use of this medication.

Patients are advised to consult a healthcare provider, such as a doctor or pharmacist, prior to use if they are currently taking any prescription medications. This is particularly important as antacids may interact with certain prescription drugs, potentially affecting their efficacy or safety.

In terms of general precautions, it is imperative that patients do not exceed a maximum dosage of 6 tablets within a 24-hour period. This limit applies equally to pregnant individuals, who should also adhere to the same dosage restriction. Furthermore, the maximum dosage should not be utilized for more than 2 weeks unless specifically directed and monitored by a healthcare professional.

Currently, there are no specific laboratory tests recommended for monitoring the use of this medication. However, healthcare providers should remain vigilant and assess the patient's overall health and medication regimen to ensure safe and effective use.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product. It is important to note that antacids may interact with certain prescription drugs, which could lead to unintended effects or reduced efficacy of the medications.

In clinical practice, it is advised that patients do not exceed a dosage of 6 tablets within a 24-hour period. This recommendation applies equally to pregnant individuals, who should also adhere to the same maximum dosage limit. Furthermore, patients are cautioned against using the maximum dosage for more than 2 weeks unless under the guidance and supervision of a healthcare professional.

To ensure safety, this product should be kept out of reach of children to prevent accidental ingestion and potential harm.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Tums (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may chew 2-4 tablets as symptoms occur, or as directed by a healthcare professional. It is important that the tablets are chewed or crushed completely before swallowing to ensure proper administration.

Care should be taken to keep the medication out of reach of younger children to prevent accidental ingestion.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should not exceed a dosage of 6 tablets within a 24-hour period. This limitation is crucial to minimize potential risks to fetal outcomes. Healthcare professionals are advised to counsel women of childbearing potential regarding the importance of adhering to this dosage recommendation during pregnancy to ensure the safety of both the mother and the developing fetus.

Lactation

There are no specific warnings or recommendations regarding the use of TUMS Chewy Bites Raspberry Lemonade in lactating mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants when this product is used during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and adhere to standard protocols for managing suspected cases of drug overdose.

In the event of an overdose, it is recommended that healthcare providers monitor the patient closely for any potential symptoms that may arise. General supportive measures should be implemented, including maintaining airway patency, ensuring adequate ventilation, and providing cardiovascular support as necessary.

If an overdose is suspected, immediate medical attention should be sought. Healthcare professionals may consider contacting a poison control center for guidance on the management of the situation. It is essential to document any symptoms observed and the actions taken in response to the overdose.

As there is no specific antidote or treatment protocol outlined for this medication's overdosage, the focus should remain on symptomatic and supportive care until further information becomes available.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients not to exceed a maximum of six tablets within a 24-hour period. This limit is crucial for ensuring safety and minimizing the risk of adverse effects.

For patients who are pregnant, it is particularly important to emphasize that they should also adhere to the same maximum dosage of six tablets in a 24-hour period. Providers should discuss the potential risks associated with exceeding this dosage during pregnancy.

Additionally, healthcare providers should inform patients that the maximum dosage should not be used for more than two weeks unless specifically directed and monitored by a physician. This guidance is essential to prevent potential complications and ensure appropriate management of their condition.

Storage and Handling

The product is supplied in a configuration that includes an inner safety seal under the cap. It is imperative that the product is not used if this seal is broken or missing, as this may compromise the integrity of the product.

For optimal storage, the product should be kept at a temperature not exceeding 25°C (77°F). Care should be taken to ensure that the storage environment maintains this temperature range to preserve the product's efficacy and safety.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients to consult a doctor or pharmacist prior to use if they are currently taking any prescription medications, as antacids may interact with certain drugs. Patients are also cautioned not to use the medication for symptoms that persist for more than two weeks without medical advice.

Drug Information (PDF)

This file contains official product information for Tums, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)